This article is part of our special report Cardiovascular disease and cholesterol.
?In an interview at the European Atherosclerosis Society (EAS) Congress, Alberico L. Catapano said that Heterozygous FH is the “most frequent monogenic disease” in Europe. The University of Milan researcher called on the European Union to “urge member states to provide information to physicians in order to be able to detect to the disease” and to support additional genetic research into FH.
Catapano said that the Netherlands is the front-runner for identifying the disease in the EU, because of a government programme that detects up to 70% of potential cases. But, he added, there are wide differences between member states. “There are countries like mine,” he said, “where a minority of the people are detected because we have never had this kind of project. So, in Italy we have 2 to 3 percent of the possible people detected.”